Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 1.00 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.68 |
| ▸ | NR1H4 | Q96RI1 | 1/20 | 0.68 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.59 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.58 |
| ▸ | MEN1 | O00255 | 1/20 | 0.57 |
| ▸ | RAB9A | P51151 | 1/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.57 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.57 |
| ▸ | NR4A2 | P43354 | 1/20 | 0.57 |
| ▸ | RXRA | P19793 | 1/20 | 0.57 |
| ▸ | RXRB | P28702 | 1/20 | 0.57 |
| ▸ | POLB | P06746 | 2/20 | 0.56 |
| ▸ | GAA | P10253 | 1/20 | 0.56 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.55 |
| ▸ | LMNA | P02545 | 1/20 | 0.54 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.54 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.53 |
| ▸ | TSHR | P16473 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ammonia Solution, Strong SCHEMBL28429402 | 0.98 | SMN1; SMN2 (0.96) | SMN1; SMN2EPHX2NR1H4ALOX15MCL1 | |
| Hydrochloric Acid SCHEMBL4640626 | 0.98 | SMN1; SMN2 (0.96) | SMN1; SMN2EPHX2NR1H4ALOX15MCL1 | |
| Formaldehyde SCHEMBL28606744 | 0.96 | SMN1; SMN2 (0.93) | SMN1; SMN2EPHX2NR1H4ALOX15MCL1 | |
| SCHEMBL3389094 | 0.89 | SMN1; SMN2 (0.79) | SMN1; SMN2EPHX2NR1H4ALOX15MEN1 | |
| SCHEMBL1507692 | 0.89 | SMN1; SMN2 (0.79) | SMN1; SMN2EPHX2NR1H4ALOX15MCL1 | |
| SCHEMBL10647892 | 0.87 | SMN1; SMN2 (0.76) | SMN1; SMN2EPHX2NR1H4ALOX15MEN1 | |
| SCHEMBL7302398 | 0.85 | SMN1; SMN2 (0.72) | SMN1; SMN2EPHX2NR1H4MEN1RAB9A | |
| SCHEMBL8219820 | 0.85 | SMN1; SMN2 (0.73) | SMN1; SMN2EPHX2NR1H4ALOX15MEN1 | |
| SCHEMBL5280680 | 0.84 | SMN1; SMN2 (0.72) | SMN1; SMN2EPHX2NR1H4ALOX15RAB9A | |
| SCHEMBL339492 | 0.83 | ALOX15 (0.81) | SMN1; SMN2ALOX15MCL1MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 188 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115108905-B | Method for producing (Z) -trifluoromethaneenol ester by copper-catalyzed regioselective olefination and trifluoromethylation of carboxylic acid | 湖南大学 | 2025-04-08 | — | — | CN | claimed |
| CN-116904764-A | Method and device for selectively extracting lithium from lithium-containing alkaline aqueous solution | 北京科技大学 | 2023-10-20 | — | — | CN | claimed |
| CN-116904765-A | Method for selectively extracting, precipitating and enriching lithium from lithium-containing alkaline aqueous solution | 北京科技大学 | 2023-10-20 | — | — | CN | claimed |
| CN-113493870-B | Composite flocculant for ion type rare earth enrichment and enrichment method | 福建省长汀金龙稀土有限公司 | 2023-04-07 | — | — | CN | claimed |
| CN-113493870-A | Composite flocculant for ion type rare earth enrichment and enrichment method | 厦门钨业股份有限公司 | 2021-10-12 | — | — | CN | claimed |
| CN-111417618-A | Process for preparing enantiomerically and diastereomerically enriched cyclobutaneamines and cyclobutaneamides | 先正达参股股份有限公司 | 2020-07-14 | — | — | CN | claimed |
| US-20130165446-A1 | BENZO-OR PYRIDO-IMIDAZOLE DERIVATIVE | HORIKOSHI, HIROYOSHI (CA) | 2013-06-27 | — | — | US | claimed |
| EP-2581373-A1 | BENZO- OR PYRIDO-IMIDAZOLE DERIVATIVE | Fujita, Takashi (JP) | 2013-04-17 | — | — | EP | claimed |
| JP-63041403-A | — | — | None | — | — | JP | disclosed |
| US-12630497-B2 | Compound having malate dehydrogenase inhibitory activity and pharmaceutical composition for preventing or treating cancer comprising same as active ingredient | DONGGUK UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION (KR) | 2026-05-19 | — | — | US | disclosed |
| US-20260083724-A1 | COMPOUNDS TARGETING PAX3::FOXO1 FUSION PROTEIN | GEORGETOWN UNIVERSITY (US) | 2026-03-26 | — | — | US | disclosed |
| EP-3710422-B1 | PROCESS FOR THE PREPARATION OF ENANTIOMERICALLY AND DIASTEREOMERICALLY ENRICHED CYCLOBUTANE AMINES AND AMIDES | SYNGENTA CROP PROTECTION AG (CH) | 2026-01-07 | — | — | EP | disclosed |
| CN-115108905-B | Method for producing (Z) -trifluoromethaneenol ester by copper-catalyzed regioselective olefination and trifluoromethylation of carboxylic acid | 湖南大学 | 2025-04-08 | — | — | CN | disclosed |
| CN-118146176-B | GPR133/ADGRD1 agonist, preparation method and application thereof | 山东大学 | 2024-11-15 | — | — | CN | disclosed |
| US-4310512-A | Derivatives of acetic and propionic acids, compositions containing same and use as malodor counteractants | BUSH BOAKE ALLEN INC. (US) | 1982-01-12 | — | — | US | disclosed |
| US-4215009-A | COMPLEXING | ORONZIO DENORA IMPIANTI ELETTROCHIMICI S.P.A. (IT) | 1980-07-29 | — | — | US | disclosed |
| US-4090862-A | Novel phenoxycarboxylic acid aryloxy(thio)carbonylaminomethyl esters and their use for regulating plant growth | BAYER AKTIENGESELLSCHAFT (DT) | 1978-05-23 | — | — | US | disclosed |
| US-4013451-A | 2-(SUBSTITUTED PHENOXY)PROPIONIC ACID | PHILAGRO S.A. (FR) | 1977-03-22 | — | — | US | disclosed |
| US-3980687-A | Intermediates for the preparation of 17-substituted-Δ4 -gonenes | ROUSSEL-UCLAF (FR) | 1976-09-14 | — | — | US | disclosed |
| US-3975413-A | Novel haptenes and antigens | PIERDET ANDRE | 1976-08-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12630497-B2 | Compound having malate dehydrogenase inhibitory activity and pharmaceutical composition for preventing or treating cancer comprising same as active ingredient | MDH2, MDH1, ME2 | SMN1; SMN2 2420/4885EPHX2 3824/4885NR1H4 966/4885 |
| US-20260083724-A1 | COMPOUNDS TARGETING PAX3::FOXO1 FUSION PROTEIN | PAX3, FOXO1, PAXBP1 | SMN1; SMN2 48/4885EPHX2 4806/4885NR1H4 4658/4885 |
| US-20130165446-A1 | BENZO-OR PYRIDO-IMIDAZOLE DERIVATIVE | PPARG, PPARA, PPARD | SMN1; SMN2 4460/4885EPHX2 3143/4885NR1H4 109/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.